Filing Details
- Accession Number:
- 0000899243-16-025726
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-07-26 17:14:57
- Reporting Period:
- 2016-07-22
- Filing Date:
- 2016-07-26
- Accepted Time:
- 2016-07-26 17:14:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1374690 | Zafgen Inc. | ZFGN | Pharmaceutical Preparations (2834) | 203857670 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1611048 | E. Thomas Hughes | C/O Zafgen, Inc. 175 Portland Street, 4Th Floor Boston MA 02114 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-07-22 | 25,000 | $0.75 | 48,936 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2016-07-22 | 5,000 | $3.02 | 53,936 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2016-07-22 | 25,000 | $0.00 | 25,000 | $0.75 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 18,928 | 2018-12-15 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.015 to 3.04, inclusive. The reporting person undertakes to provide to Zafgen, Inc., any security holder of Zafgen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
- Fully vested.
- Includes 2,276 shares acquired under Zafgen, Inc.'s 2014 Employee Stock Purchase Plan (the "Plan") on July 1, 2016, and 340 shares acquired under the Plan on January 1, 2016.
Billionaire Hedge Funds
